OS Therapies Incorporated
OS Therapies Incorporated (OSTX) Revenue
Annual & quarterly revenue history · segment & region breakdown
OSTX · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsOS Therapies Incorporated trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income OS Therapies Incorporated receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
OS Therapies Incorporated reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from OS Therapies Incorporated's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
OSTX revenue · 4 questionsOSTX's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · OS Therapies Incorporated SEC filings · GAAP · OS Therapies Incorporated SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026